Milnacipran
Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) primarily used to manage symptoms associated with Fibromyalgia. While its biological mechanism is similar to various Antidepressants, its clinical application often focuses on pain regulation rather than mood management alone. For this specific use, Savella is the pharmaceutical product available.
Key points
- Though its mechanism resembles other antidepressants, it is formulated specifically to ease the widespread pain, fatigue and tenderness of fibromyalgia.
- This medicine is reserved for the chronic pain pattern of fibromyalgia rather than everyday acute or minor aches.
- Savella remains the leading branded option, supplied as a film-coated tablet designed to aid swallowing and digestion.
- By boosting serotonin and norepinephrine at nerve junctions, it strengthens signals that dampen how pain is perceived.
What is Milnacipran?
Milnacipran is a pharmaceutical medication that helps regulate neurotransmitters within the nervous system. It primarily targets chemicals known as serotonin and norepinephrine, which are involved in transmitting pain signals and regulating mood. It is distinct because its specific formulation profile targets chronic pain conditions.
What Milnacipran is used for
Milnacipran is primarily used to address symptoms of Fibromyalgia. By modulating the chemical signals that influence pain perception, this medication aims to reduce the intensity of widespread musculoskeletal pain, fatigue, and tenderness. It is not intended for general acute pain or for minor aches.
How does Milnacipran work?
This medicine works by blocking the reabsorption of serotonin and norepinephrine at the synapse, which is the junction between nerves. By increasing the availability of these neurotransmitters in the gaps between nerve cells, it enhances the signals that block pain. This process helps modify how the body alters and responds to pain sensations over time.
Milnacipran brands and forms
The pharmaceutical field for this ingredient is currently dominated by the originator product, Savella. While many classes of Antidepressants exist, Milnacipran is formulated specifically for its pain-management properties. It is commonly delivered in the following format:
- Film-coated tablet
The film coating is designed to protect the medication and assist with its swallowing and digestion.
Safety overview for Milnacipran
What to check before using this medicine
Ensure you have disclosed any history of kidney or liver conditions to your provider. It is important to confirm that this medication does not conflict with any existing treatments.
Possible reactions and tolerability
Common responses may include nausea, dizziness, or changes in heart rate. Many physical reactions depend on the individual and how their system processes the medication.
Interactions and health factors
Alcohol and other central nervous system-impacting substances can alter how this medicine performs. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.